本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Terns Pharmaceuticals, Inc.

4.32
+0.06001.41%
盘后4.23-0.0900-2.08%14:49 EDT
成交量:26.32万
成交额:113.03万
市值:3.77亿
市盈率:-4.00
高:4.36
开:4.30
低:4.21
收:4.26
数据加载中...
2023/03/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/13

重要事件披露

8-K - Current report
2023/03/02

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/08

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/05

重要事件披露

8-K - Current report
2023/01/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/23

重要事件披露

8-K - Current report
2022/12/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/11/09

重要事件披露

8-K - Current report